Ålgars, Monica
Räisänen, Laura
Lommi, Sohvi
Koivusalo, Saila
Viljakainen, Heli
Funding for this research was provided by:
Foundation of Pediatric Research (240050)
the State funding for university-level health research, Tampere University Hospital, Wellbeing services county of Pirkanmaa (T63344/50621)
the Orion Research Foundation
University of Helsinki
Article History
Received: 28 November 2024
Accepted: 17 April 2025
First Online: 3 May 2025
Declarations
:
: The Fin-HIT study protocol was approved by the Coordinating Ethics Committee of the Hospital District of Helsinki and Uusimaa (169/13/03/00/10), and the study adhered to the Declaration of Helsinki. Participants and one guardian per child provided their written informed consent.
: Financial interests MÅ has received speaker honoraria from Gedeon Richter pharmaceutical company and receives a salary from Mehiläinen. The other authors have no competing interests to declare.